This graphic, which appears in the AVAC Report 2014/15: HIV Prevention on the Line, depicts global ART coverage.
Global ART Coverage (2014)
What to Expect for PrEP in Africa in 2015
Appearing in the AVAC Report 2014/15: HIV Prevention on the Line, this graphic shows ongoing and completed PrEP trials in Africa.
Global HIV Prevention R&D Investment 2009-2013
Appearing in AVAC Report 2014/15: HIV Prevention on the Line, this graphic shows the global HIV prevention research and development investment from 2009-2013.
Px Wire January-March 2015, Vol. 8, No. 1
Px Wire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. This issue includes a highly selective list of ten issues, events and developments to hold attention and spark actions in 2015—and beyond. This issue is also available as a webpage.
AVAC Report 2014/15: Prevention on the Line [Executive Summary]
This executive summary, excerpted from AVAC Report 2014/15, puts the current discussion about global targets for ending AIDS in context. What makes a good target? What targets have worked in the past—and why? What is the state of HIV prevention targets and plans today?
Biomedical HIV Prevention Efficacy Trials, 2014–2016
Hormonal Contraceptives and HIV – An introductory fact sheet
This introductory 3-page document summarizes the debate over whether certain hormonal contraceptives increase women’s risk of HIV acquisition. For more basic fact sheets, visit www.avac.org/intro.
Regulatory Mapping Project
AVAC undertook this review of activities designed to strengthen regulatory capacity, particularly in Africa. This included a desk review of various planned or ongoing activities and interviews with key informants. The results are summarized by country, initiative, and objective among other parameters.
Essential Actions for HIV Prevention Research Rollout 2014/15
This updated version of AVAC’s 3D graphic shows priorities across the research-to-rollout spectrum. The graphic appears in AVAC Report 2014/15: Prevention on the Line.
FY2015 US Global AIDS Budget Plan: The Human Impact
The US government’s efforts to fight the global AIDS pandemic through both the US President’s Emergency Plan for AIDS Relief (PEPFAR) and The Global Fund to Fight AIDS, Tuberculosis and Malaria have been transformative in the global AIDS response. To maintain the current total level of US global HIV/AIDS funding in Fiscal Year 2015, the US House of Representatives has proposed restoring US$300 million in PEPFAR funding. As illustrated in this infographic, amfAR has estimated the potential human impact of US$300 million to expand lifesaving HIV prevention, Treatment U=U and care services.